Toxic multinodular goiter laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Toxic multinodular goiter}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References=...")
 
 
(10 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Toxic multinodular goiter}}
{{Toxic multinodular goiter}}
Please help WikiDoc by adding content hereIt's easy! Click [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}; {{AE}} {{Mazia}}
==Overview==
Diagnosis of multinodular goiter is made by measurement of  serum [[thyroid-stimulating hormone]] ([[TSH]])  , serum free [[T4]] test , [[total thyroxine]] (T4) and  free [[triiodothyronine]] (T3).
 
==Laboratory Findings==
*Diagnosis of multinodular goiter is made by measurement of serum [[thyroid-stimulating hormone]] (TSH) , serum free [[T4]] test , total [[thyroxine]] (T4) and free [[triiodothyronine]] (T3).<ref name="pmid26462967">{{cite journal |vauthors=Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L |title=2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer |journal=Thyroid |volume=26 |issue=1 |pages=1–133 |year=2016 |pmid=26462967 |pmc=4739132 |doi=10.1089/thy.2015.0020 |url=}}</ref>
*Additional tests include:
**Serum [[thyroglobulin]] and [[thyroid autoantibodies]] to detect [[autoimmunity]] that may co-exist with [[goiter]] and [[lung function testing]].
**Urinary [[iodine]] excretion can be measured in case of suspected [[iodine]] excess.
*Laboratory findings consistent with the diagnosis of multinodular goiter include:<ref name="pmid12588812">{{cite journal |vauthors=Hegedüs L, Bonnema SJ, Bennedbaek FN |title=Management of simple nodular goiter: current status and future perspectives |journal=Endocr. Rev. |volume=24 |issue=1 |pages=102–32 |year=2003 |pmid=12588812 |doi=10.1210/er.2002-0016 |url=}}</ref>
**[[TSH]] is usually normal or decreased.
**Free [[T4]], and free [[T3]] is usually normal or elevated.
**An isolated increase in [[T4]] is observed in:
***[[Hyperthyroidism]] induced by [[iodine]]
***[[Hyperthyroidism]] due to agents that reduce peripheral conversion of [[T4]] to [[triiodothyronine]] (T3) like:<ref name="pmid26462967">{{cite journal |vauthors=Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L |title=2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer |journal=Thyroid |volume=26 |issue=1 |pages=1–133 |year=2016 |pmid=26462967 |pmc=4739132 |doi=10.1089/thy.2015.0020 |url=}}</ref>
****[[Propranolol]]
****[[Corticosteroids]]
****[[Radiocontrast agents]]
****[[Amiodarone]]
**Serum [[thyroglobulin]] is usually elevated.
**[[Thyroid autoantibodies]] ([[thyroperoxidase]] antibodies and [[thyroglobulin antibody]]) usually negative.
**Some patients with multinodular goiter may have impaired inspiratory capacity on [[lung function testing]].
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Endocrinology]]


{{WikiDoc Help Menu}}
{{WH}}
{{WikiDoc Sources}}
{{WS}}

Latest revision as of 16:03, 13 October 2017

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter laboratory findings

CDC on Toxic multinodular goiter laboratory findings

Toxic multinodular goiter laboratory findings in the news

Blogs on Toxic multinodular goiter laboratory findings

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Diagnosis of multinodular goiter is made by measurement of serum thyroid-stimulating hormone (TSH) , serum free T4 test , total thyroxine (T4) and free triiodothyronine (T3).

Laboratory Findings

References

  1. 1.0 1.1 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016). "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer". Thyroid. 26 (1): 1–133. doi:10.1089/thy.2015.0020. PMC 4739132. PMID 26462967.
  2. Hegedüs L, Bonnema SJ, Bennedbaek FN (2003). "Management of simple nodular goiter: current status and future perspectives". Endocr. Rev. 24 (1): 102–32. doi:10.1210/er.2002-0016. PMID 12588812.

Template:WH Template:WS